In today’s article, our Chief Scientific Officer, Prof. Martin Dawes will discuss the role of pharmacogenetics in treating depression. You’ll also learn about a solution that enables the use of evidence-based pharmacogenetics at the point of care....
In this interview with our Algorithm Team Manager, Andrea Paterson, she talks about the exciting updates on our TreatGx software, and how to use it to select the best medication options for patients with depression. ...
Do you sometimes feel down, unengaged, or depressed? You are not alone! In North America, the impact of mental illnesses is huge and intractable. One in five U.S. adults experiences mental illness each year. Similarly, 1 in 5 Canadians experiences a mental illness or addiction problem...
If you work in healthcare, you probably heard of the word “Interoperability” at least once, or perhaps too many times. Whether you heard it from a co-worker or your favorite healthcare influencer, health data interoperability is becoming more important than ever. But does it live...
What is pharmacogenetics, and how can pharmacogenetics be helpful to doctors? In our Precision Insights Podcast, Dr. Martin Dawes interviewed Sue Paul of SyneRxgy Consulting, a company that aims to simplify patients' medication lists and help improve medication adherence. Sue shares her experience in implementing pharmacogenetic information...
Why is making sure employees are complying with their medications so important? Not taking medicine prescribed by healthcare providers could lead to employee’s health conditions getting worse, hospitalizations, or even death. Learn how to play an active role in ensuring your employees are taking their...
GenXys Health Care Systems is proud to share that Sun Life selected TreatGx plus as part of its disability management toolkit for plan sponsors. According to Sun Life, the goal is to help plan members get back to work faster and live healthier lives....
Starting in October, UnitedHealth Group will cover PGx tests for patients with major depressive disorder or anxiety, who have experienced treatment failure at least once. Learn more about what this means for you as employers. ...
"The new US precision medicine initiative, including the All of Us program, has been made possible by improvement and price reduction in genome sequencing, as well as advances in multiple sectors of biotechnology. The initiative includes two components: a focus on cancer intended to spur...
The results of the Steroids in Eosinophil Negative Asthma (SIENA) trial emphasize the importance of a personalized approach to the treatment of asthma. For a given condition, there are likely many different subtypes of patients who may respond differently to different medications. In this case,...
